Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anuj Gaggar

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectorsKathrin M Bernt, Shaoheng Ni, Anuj Gaggar, et al.
Journal of Medical Virology|July 2, 2020
Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencingYang Liu, Lindsey May, Xinan Liu, et al.
Journal of Virology|August 28, 2004
Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific mannerDmitry M Shayakhmetov, Zong-Yi Li, Anuj Gaggar, et al.
Plos One|July 30, 2019
Genomic modeling of hepatitis B virus integration frequency in the human genomeOndrej Podlaha, George Wu, Bryan Downie, et al.
Journal of Virology|March 30, 2005
Development and assessment of human adenovirus type 11 as a gene transfer vectorDaniel Stone, Shaoheng Ni, Zong-Yi Li, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|October 19, 2020
PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3Tanvi Agrawal, Anuj Gaggar, Mani Subramanian, et al.
Journal of Hepatology|September 6, 2017
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistanceGlenda Grossi, Alessandro Loglio, Floriana Facchetti, et al.
Vaccine|July 22, 2014
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized studyAnuj Gaggar, Claire Coeshott, David Apelian, et al.
Journal of Viral Hepatitis|May 18, 2021
Hepatitis B virus genome diversity in adolescents: Tenofovir disoproxil fumarate treatment effect and HBeAg serocon versionChristophe Combet, Neeru Bhardwaj, Charlotte Hedskog, et al.
BMC Bioinformatics|September 3, 2016
Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interactionXiaojun Xu, Hong Thai, Kathryn M Kitrinos, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectorsKathrin M Bernt, Shaoheng Ni, Anuj Gaggar, et al.
Journal of Medical Virology|July 2, 2020
Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencingYang Liu, Lindsey May, Xinan Liu, et al.
Journal of Virology|August 28, 2004
Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific mannerDmitry M Shayakhmetov, Zong-Yi Li, Anuj Gaggar, et al.
Plos One|July 30, 2019
Genomic modeling of hepatitis B virus integration frequency in the human genomeOndrej Podlaha, George Wu, Bryan Downie, et al.
Journal of Virology|March 30, 2005
Development and assessment of human adenovirus type 11 as a gene transfer vectorDaniel Stone, Shaoheng Ni, Zong-Yi Li, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|October 19, 2020
PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3Tanvi Agrawal, Anuj Gaggar, Mani Subramanian, et al.
Journal of Hepatology|September 6, 2017
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistanceGlenda Grossi, Alessandro Loglio, Floriana Facchetti, et al.
Vaccine|July 22, 2014
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized studyAnuj Gaggar, Claire Coeshott, David Apelian, et al.
Journal of Viral Hepatitis|May 18, 2021
Hepatitis B virus genome diversity in adolescents: Tenofovir disoproxil fumarate treatment effect and HBeAg serocon versionChristophe Combet, Neeru Bhardwaj, Charlotte Hedskog, et al.
BMC Bioinformatics|September 3, 2016
Modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interactionXiaojun Xu, Hong Thai, Kathryn M Kitrinos, et al.
Pageof 10